Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LR-PRP vs Percutaneous Tenotomy for Chronic Common Extensor Tendinopathy
NCT04384809Phase 4Withdrawn
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jan 2023
- Primary completion
- May 2023
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Leukocyte-Rich Platelet-Rich Plasma in Lateral Epicondylitis (LET) (2 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoints: Change in pain: visual analogue scale at 12 months and Change in function at 12 months. Planned start Jan 2023; status: withdrawn.
02
Drugs
Leukocyte-Rich Platelet-Rich Plasma
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT04384809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04384809.